🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Join us tomorrow (Monday, 4/21) @ 1-2 pm Central Time for the NCS Pharmacy Journal Club presentations! Exciting articles will be reviewed!! Neurocritical Care Society Casey C. May, PharmD, BCCCP, FNCS Karen Berger Colleen Barthol, PharmD, BCCCP, FNCS Andy Webb

‼️🚨⏰🔔⏲️ happening in 15 min! Are you ready?!! 👇👇👇

we are going LIVE NOW!!! Neurocritical Care Society

Nice review of cerebral edema management including novel therapies!! Karen Berger Neurocritical Care Society

Nice review of MOA of Glibenclamide for cerebral edema!! #NCSPharmJC

Review of prior studies⏰

Time to discuss CHARM 😃#NCSPharmJC

What did CHARM show?

Maybe there is signal here?!! #CHARMTrial #NCSPharmJC Karen Berger

CHARM Conclusions!!

Up next! Casey C. May, PharmD, BCCCP, FNCS Neurocritical Care Society

History behind these agents!! #NCSPharmJC

PK Pearls!!

Study methods! RCT in 33 Chinese centers 👇

What outcomes were they looking for??

What did they find?? Karen Berger

No difference in ADR rates?

What are the major take away points from this trial? Casey C. May, PharmD, BCCCP, FNCS Neurocritical Care Society

#Mondaytip ☝️After #ICH, patients aren't only at risk of recurrence but also IS👉especially w/AF After COCROACH metaanalysis, PRESTIGE-AF is the 1st large RCT to provide new data ⚖️Stroke prevention and bleeding risk remains critical Awaiting results from at least 2+ ongoing RCTs

🚨I'm excited to share a viewpoint article on navigating IV fluid shortages in neurocritical care that I had the honor of collaborating on with an outstanding team Scott Sousa DeBoer!💧💉 Neurocritical Care 👇The reality is that drug shortages are here to stay! pubmed.ncbi.nlm.nih.gov/40279012/